Trawick, G. R. "Rick"

David is a member of MDWC&G's Healthcare Liability Practice Group and the Medical Device and Pharmaceutical Litigation Practice Group.

He graduated cum laude from Temple University and earned a B.S. in Biology with an emphasis in Molecular Biology. David then worked as an organic and combinatorial chemist for Rhone-Poulenc-Rorer Pharmaceuticals where he helped develop a novel activated resin for chemical library synthesis. He then joined the gene therapy/cardiovascular department where he conducted extensive research into the molecular mechanism and possible treatments of cardio infarctions.

In May of 2000, David joined the immunology/oncology department of Sanofi-Aventis Pharmaceuticals. Here he managed a portfolio of potential drug candidates. It was during this time that David became admitted to the Patent Bar and conducted strategic analysis related to potential new drug candidates. In 2005, he graduated from Rutgers School of Law - Newark. 

After graduation he litigated product liability, medical malpractice and commercial matters.  He was also involved in developing corporate compliance guidelines for a major healthcare corporation. 

David has experience litigating complicated environmental coverage actions.  He is also involved in handling complex, multi-party litigation, including the litigation of class actions and matters handled through the Federal Multi-District Litigation program.

David was admitted to the New Jersey and Pennsylvania State Bars, the Third Circuit Court of Appeals, the United States District Court, District of New Jersey, and the Eastern District of Pennsylvania.  With over 10 years of research and development activities in both chemistry and biology for major pharmaceutical companies, he brings a wealth of experience to the firm.